Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00068952
Status:
COMPLETED
Last Update Posted:
2008-04-01
First Post:
2003-09-12
Brief Title:
Study of IV Edotecarin Vs Temozolomide or Carmustine BCNU or Lomustine CCNU in Patients With Glioblastoma Multiforme
Sponsor:
Pfizer
Organization:
Pfizer
Organization Data
Organization:
Pfizer
Class:
INDUSTRY
Study ID:
EDOAGL-8725-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Pfizer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None